Correction to: Spartalizumab in combination with platinum-doublet chemotherapy with or without canakinumab in patients with PD-L1-unselected, metastatic NSCLC (BMC Cancer, (2024), 24, 1, (1307), 10.1186/s12885-024-12841-2)

Armando Santoro, Garrido Pilar, Daniel S.W. Tan, Jon Zugazagoitia, Frances A. Shepherd, Alessandra Bearz, Fabrice Barlesi, Tae Min Kim, Tobias R. Overbeck, Enriqueta Felip, Can Cai, Simantini Eddy, Tracey McCulloch, Eric S. Schaefer

    Résultats de recherche: Contribution à un journal!!Comment/debate

    Résumé

    Following publication of the original article [1], the authors identified an error in the author name of Simantini Eddy. Their given name and family name were erroneously transposed. The incorrect author name is: Eddy Simantini The correct author name is: Simantini Eddy The author group has been updated above and the original article [1] has been corrected.

    langue originaleAnglais
    Numéro d'article1436
    journalBMC Cancer
    Volume24
    Numéro de publication1
    Les DOIs
    étatPublié - 1 déc. 2024

    Contient cette citation